HIPAA Security Risk Analysis: A Critical Compliance Obligation for Pharmacies  

Cyberattacks against healthcare organizations continue to rise and pharmacies remain attractive targets because they store and transmit large volumes of protected health information (PHI). As a result, the HIPAA Security Rule’s risk analysis requirement has become a primary enforcement priority for the Office for Civil Rights (OCR). Recent enforcement actions demonstrate that failing to perform and document a comprehensive risk analysis can be as costly as a cyber-attack itself. The recent June 18, 2026, OCR report marked the 20th Ransomware Enforcement Action and 14th Risk Analysis Initiative Enforcement Action with a settlement of $450,000 following a ransomware incident that affected just 10,000 individuals. OCR found that the organization failed to conduct an accurate and thorough risk analysis before the breach occurred and had not implemented appropriate compliance measures. In addition to the monetary settlement, the organization was required to complete a corrective action plan under federal oversight.

A HIPAA risk analysis is a required assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of electronic PHI (ePHI). According to HHS, a risk analysis is the foundation of Security Rule compliance and the first step in determining what safeguards are needed to protect patient information. Every covered entity (including pharmacies) must conduct an accurate and thorough assessment of its risks.

For pharmacies, a risk analysis should examine all systems and processes that create, receive, maintain, or transmit ePHI. This includes pharmacy management systems, dispensing software, point-of-sale systems, e-prescribing platforms, mobile devices, email, cloud applications, backups, and third-party vendors that have access to patient data. HHS emphasizes that organizations must identify where ePHI resides, understand how it flows through the organization, and evaluate threats ranging from ransomware and unauthorized access to natural disasters and accidental workforce errors.

A practical risk analysis generally includes several key steps, such as:

  1. An inventory of all locations where ePHI exists.
  2. Identifying potential threats and vulnerabilities.
  3. Assessing current security controls.
  4. Evaluating the likelihood and potential impact of each risk.
  5. Assigning risk levels and developing a written plan to address identified gaps.

This entire process must be documented, as OCR expects covered entities to produce written evidence of both the analysis and the resulting risk management activities. Just as important, a risk analysis is not a one-time exercise. OCR increasingly expects healthcare organizations to maintain a current assessment that reflects changes in technology, staffing, operations, remote access, and cyber threats. OCR enforcement actions repeatedly cite organizations that either never completed a risk analysis or failed to update one that had become outdated.

The consequences of neglecting this requirement can be significant. Not only may the pharmacy’s systems be vulnerable to internal and external threats, but OCR enforcement and settlements can be pricey. For pharmacies, the lesson is clear – cybersecurity and HIPAA compliance begins with understanding your risks. Pharmacies that can show they have identified risks, implemented safeguards, trained workforce members, and periodically reassessed their environment are in a far stronger position to protect patient data and defend their compliance efforts.

A robust HIPAA risk analysis is more than a regulatory requirement – it is an essential business practice.

PAAS Tips:

  • The PAAS National® FWA/HIPAA Compliance Program provides pharmacies with numerous resources, including a step-by-step guide of the risk analysis process
  • Although HIPAA does not mandate a specific review cycle, pharmacies should conduct and document a comprehensive risk analysis at least annually, and whenever significant operational, technological, or security changes occur.
Sara Hathaway, PharmD